Medical polyacrylamide hydrogel injection for augmentation of postoperative complications and clinical research progress.doc

 PAGE \* MERGEFORMAT 20 Medical polyacrylamide hydrogel injection for augmentation of postoperative complications and clinical research progress [Keywords:] medical polyacrylamide hydrogel injection for augmentation complications Polyacrylamide gel (polyacryamide hydrogel, PAHG is colorless and transparent polymer gel, the polyacrylamide and water for injection formulated in accordance with a certain percentage of .1997 by the end of the introduction of the product from the Ukraine, China, named “ British Jierfale “, 1999, domestic medical polyacrylamide hydrogel licensing, trade name Amazingel, because of its simple operation, no surgery, no surgical scar, less pain, so the products were once regarded as good organizational filler, is widely used in the field of cosmetic surgery, especially in breast augmentation surgery have a lot of applications. But as time goes on, there has been a lot of complications, and there Zhushe easy to remove difficulties and other issues, In 2006 the State Food and Drug Administration to stop its production and use. In recent years, many domestic scholars injection for augmentation and clinical treatment for complications related reports, are summarized below. 1 type of complication and key performance Polyacrylamide hydrogel injection for augmentation of the complications include: lumps or sclerosis, aseptic inflammation, pectoralis major muscle inflammation, bilateral breast asymmetry, rubber cement-like changes, pain, infection, breast rupture, leakage, lactation mastitis, upper extremity activity limitation, non-perforation of the breast skin incision, injection of polyacrylamide hydrogel shift, parcels sclerosis, etc., some complications in patients with several co-exist. Zhou Zhi induration or lumps 1.1 [1] Summary of 900 cases of complications, sclerosis accounted for 58.89%, and the spread of induration, diffuse and diffuse (whole breast hard) induration. Yueying [2] that the induration PAHG injection is th